Last update 08 Nov 2025

Anti-CD123 CAR-T-cell therapy (Wuhan Bio Raid Biotechnology)

Overview

Basic Info

Drug Type
CAR-T
Synonyms
AntiCD123 CARTcell therapy Wuhan Bio Raid Biotechnology
Target
CD123
Action
inhibitors
Mechanism
CD123 inhibitors(Interleukin-3 receptor subunit alpha inhibitors), Gene transference(Gene transference), T lymphocyte replacements
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
CD123 Positive Acute Myeloid Leukemia
Originator Organization
Wuhan Bio-Raid Biotechnology Co., Ltd.Wuhan Bio-Raid Biotechnology Co., Ltd.
Active Organization-
Inactive Organization
Wuhan Bio-Raid Biotechnology Co., Ltd.Wuhan Bio-Raid Biotechnology Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Anti-CD123 CAR-T-cell therapy (Wuhan Bio Raid Biotechnology)
NCT04014881
/ Unknown statusPhase 1IIT
Single-center, Open-label, Single-arm Clinical Study of Efficacy and Safety of Anti-CD123 CAR-T Therapy in Patients With Refractory/Relapsed CD123+ Acute Myeloid Leukemia.
100 Clinical Results associated with Anti-CD123 CAR-T-cell therapy (Wuhan Bio Raid Biotechnology)
Login to view more data
100 Translational Medicine associated with Anti-CD123 CAR-T-cell therapy (Wuhan Bio Raid Biotechnology)
Login to view more data
100 Patents (Medical) associated with Anti-CD123 CAR-T-cell therapy (Wuhan Bio Raid Biotechnology)
Login to view more data
100 Deals associated with Anti-CD123 CAR-T-cell therapy (Wuhan Bio Raid Biotechnology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CD123 Positive Acute Myeloid LeukemiaPhase 1
China
Wuhan Bio-Raid Biotechnology Co., Ltd.Wuhan Bio-Raid Biotechnology Co., Ltd.
06 Jul 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free